Financial

If you recall in 2022, Bioventus planned to acquire CartiHeal for $450M (4X sales), but Bioventus spit them out – […]

Earlier this year I wrote about all the things that Treace is doing right here – Stepping into the future:

Wow! This is a big one! This big casualty resulted because of runaway expenses and lack of focus. Once again,

Expands Xtant’s Manufacturing Capabilities and Capacity to Drive Growth Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology

Takeaway Message: In 2024, look for DePuy-Synthes to spin out poor divisions and/or product lines and to acquire brand new

5 financial challenges facing the medtech sector (MedTechDive) As medical device leaders gather this week at AdvaMed’s annual Medtech Conference, several

Rebecca Whitney, President of ZimVie spine. The President of ZimVie Spine, recently conducted a Q&A session with MedTechDive, prompting me

Strange bed fellows! My initial thought is that Enovis made this acquisition for three reasons: 1) For the global reach

Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M (MedDevice) Boston Scientific(NYSE: BSX)+ announced today that it entered

We always assume that the next new sale is good business. More sales, more profit. But not all sales are

Here we go! It’s only been a week since the Conformis acquisition closing and Restor3d needs more capital. Not sure

Class action lawsuits like this help to make the case for single-use sterile instruments. At least one death, “hundreds of

In the dynamic realm of medical device startups, securing essential capital is a make-or-break endeavor that fuels innovation and progress.

In our dynamic world of orthopedics, external market financial trends can wield considerable influence on companies. These trends often operate

Augmedics may have just grabbed the deal of the century. A quick background and three thoughts. Background: Surgalign spent $125M

In the ever-evolving realm of orthopedics, a counterintuitive insight challenges conventional thinking: Owning the most advanced technology or best product

Why is Proprio important? The Proprio Paradigm technology has the potential to revolutionize orthopedic and spine surgery in a number

Orthopedic companies MUST learn financial discipline in order to survive. The easy capital faucet is was turned off forever back

In reading about the failure of ViewRay and thought that it was representative of how orthopedics companies have failed in

Websites… https://curvafix.com/ https://mvm.com/ CurvaFix raises $39M, announces new CEO (MassDevice) CurvaFix announced today that it closed a $39 million equity

Smart orthopedic startups use metrics to monitor the health of their business. Below are 11 useful metrics that software startups

This is one of the single best business ideas I’ve ever heard. Any orthopedic companies can use this tool. Ortho

Zavation, a Gemspring Capital Portfolio Company, Acquires CoreLink (press release) Zavation Medical Products, LLC (“Zavation”), an innovative designer and manufacturer

Restor3d to acquire Conformis for $2.27 per share (MassDevice) websites: https://www.restor3d.com/ https://www.conformis.com/ This ends the death spiral for Conformis. ConforMIS

Surgalign reached a market cap of $180M in May 2019. They posted $117M in gross sales in 2019. Four years

Today, the Big Orthos are posting record sales, and at the same time record layoffs. I wrote about this strange

Treace Medical Concepts, Inc. PONTE VEDRA, Fla., June 01, 2023 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the

Bioventus divests wound business to LifeNet Health (MassDevice) This sale is another sign of the tight financial times. Unprofitable orthopedic

Ortho community, I need your help to make sense of this paradox. There is a financial trend going on that

Zimmer Biomet to acquire 3D-printed implant maker Ossis (MassDevice) Zimmer Biomet (NYSE: ZBH)+ announced today that it reached a definitive agreement to

We are all watching two big mergers play out in orthopedics this year. Nuvasive/Globus 8Feb2023 – announcement of merger 1Sep2023

TAKE HOME MESSAGE: ATEC has leveraged their all time high stock price, sold $66M in stock and paid $55M to

Written by Wells Fargo as an Equity Research piece on April 17, 2023. TIMELINE May2023 – Not so fast! The

Reinhold Schmieding Forbes just released their world billionaire list. Link is here. My observations: Looks like you have to work

Strengthens Foot and Ankle Portfolio with Leading Minimally Invasive Surgery (MIS) Platform, including MIS Bunion System and Furthers Global Expansion

The pandemic temporarily shifted the power dynamics between employees and employers. In 2020, during the height of the pandemic, employees

The following article reinforces my piece written after the SVB collapse titled, The effect of the SVB bank collapse on

BACKGROUND – First, a little context. SVB is not a normal consumer bank, but it “was” the 16th largest in

Xtant Medical Acquires Coflex® Product Line from Surgalign for $17 Million (press release) Expands Xtant’s Product Offering with the Leading PMA-Approved

Snapshot: I see 4 BIG RISKS with the Globus + Nuvasive merger 1/ Combining different cultures.2/ Sales & distribution integration.3/

Tweet storm from Tom Loverra ( https://twitter.com/tomloverro) I am starting to realize that many Orthopedic startups do not understand the

Tyber Medical LLC Acquires ADSM-Synchro Medical (press release) SynchroMedical website – http://www.synchromedical.com/ Tyber Medical website – https://tybermedical.com/ Acquisition of French

1/The Opening Slide – an important slide because it stays on the longest to your audience – just your Logo

Entrepreneurs, inventors and founders call me asking for advice on finding funding. They often think about the “family and friends”

I have found that many candidates interviewing at emerging orthopedic companies do not really understand the “stock equity” portion of